BMT planning in Delhi

Bone marrow transplant in Delhi

Delhi provides hematology and stem-cell transplant pathways for selected blood cancers, marrow-failure disorders, immune conditions, and inherited diseases. The meaningful comparison is not simply “BMT cost”; it is disease status, autologous or allogeneic graft, donor availability, conditioning intensity, isolation, infection response, blood support, caregiver stay, and continuity with the home hematologist.

How much should a BMT pathway in Delhi cost?

For 2026 planning, autologous BMT in Delhi may require about INR 14,00,000 to 20,00,000 (USD 14,500 to 20,800). Matched allogeneic care may be INR 20,00,000 to 35,00,000, while haploidentical, unrelated-donor, severe infection, GVHD, ICU, or graft-failure pathways can reach INR 35,00,000 to 52,00,000+ (USD 36,300 to 54,000+).

USD conversions use the RBI reference of INR 96.3665 per USD displayed for 17 July 2026. Conditioning medicines and complications make hospital quotations time-sensitive.

Review city costs Upload reports

Let Us Help You

Share the basics and the Virello team will guide you toward the next step.

Prefer email? Write to support@virellohealth.com.

Patient Name

Country

Phone Number

Describe The Current Medical Problem

Reviewed 2026-07-20

Clinical review: Virello Health Medical Review Team · Editorial review: Virello Health Editorial Team

Planning currency: INR and USD

Transplant types

Delhi bone marrow transplant context: Autologous uses the patient’s collected cells; allogeneic uses a matched related, unrelated, haploidentical, or selected cord donor source.

Admission

Delhi bone marrow transplant context: Conditioning, infusion, low-count recovery, engraftment, infection surveillance, and complications can require three to six weeks or longer in hospital.

Delhi stay

Delhi bone marrow transplant context: Families may need eight to sixteen weeks near the unit after allogeneic BMT, with frequent tests and rapid access for fever or GVHD.

Core team

Delhi bone marrow transplant context: Transplant hematology, blood bank and apheresis, HLA laboratory, infectious disease, ICU, pharmacy, pathology, nutrition, psychology, and trained nursing.

Estimate basis

Delhi bone marrow transplant context: Diagnosis, remission status, donor source, conditioning, cell procurement, medicines, blood products, infection, ICU, and length of stay determine cost.

Why this city

How Delhi may fit this treatment pathway

Delhi can be valuable when a patient needs disease re-staging, donor comparison, transplant-level hematology, complex infection support, and access to more than one institutional or private pathway. The selected unit should be judged at the campus level because room engineering, nursing, blood services, laboratory turnaround, and emergency response are not interchangeable across branches.

Hematology referral depth

Delhi supports evaluation across leukemia, lymphoma, myeloma, aplastic anemia, thalassemia, immune disorders, and selected pediatric diseases, but indication and timing remain diagnosis-specific.

Donor and HLA pathways

A suitable program should coordinate HLA typing, family testing, antibody considerations, unrelated-donor search when indicated, cell collection, transport, cryopreservation, and backup planning.

Infection and ICU access

Prolonged low counts can lead to bacterial, fungal, viral, respiratory, or bloodstream emergencies. Verify microbiology, isolation, imaging, intensive care, and antimicrobial access.

Caregiver accommodation

The caregiver may remain in Delhi for months and needs hygienic housing, transport, food, communication, and the ability to return to the unit quickly after discharge.

Candidate context

Who may be assessed for bone marrow transplant

BMT candidacy depends on diagnosis, response to previous treatment, disease risk, organ function, infection status, performance, age and frailty, donor options, fertility goals, psychosocial readiness, and whether transplant offers a reasonable benefit over non-transplant therapy. The same diagnosis can lead to different recommendations.

Disease indication and control

The hematologist reviews pathology, marrow morphology, flow cytometry, cytogenetics, molecular markers, imaging, prior regimens, response depth, and relapse risk.

Organ and infection fitness

Delhi bone marrow transplant context: Heart, lung, liver, kidney, dental, viral, tuberculosis, and active-infection assessments influence conditioning intensity, timing, prophylaxis, and ICU risk.

Donor feasibility

Related and alternative donors require HLA and health evaluation. A partial match may be usable in selected protocols, but it changes medicines, risks, and cost.

Patient and caregiver readiness

Adherence, reliable caregiver support, clean lodging, emergency access, fertility counseling, financial planning, and home-country hematology are part of safe candidacy.

Urgency and travel safety

When timing or symptoms change the plan

Fever during low counts

A temperature or infection symptom during neutropenia is an emergency requiring immediate local assessment, cultures, and antibiotics under the treating protocol.

Do not travel to Delhi first.

Bleeding or severe weakness

Delhi bone marrow transplant context: Active bleeding, breathlessness, chest pain, confusion, fainting, or profound weakness may reflect cytopenia, infection, or another emergency.

Seek urgent local stabilization.

Aggressive disease timing

Delhi bone marrow transplant context: Acute leukemia or rapidly progressive lymphoma may require time-sensitive induction, salvage, or bridging treatment before transplant can be planned.

Send current counts and pathology quickly.

Stable transplant consultation

Patients in response or with chronic disorders can compare indication, donor route, conditioning, fertility preservation, unit availability, and complete budget before travel.

Do not delay necessary local therapy.

Treatment options

The procedure name may cover different plans

Technique, disease extent, devices, medicines, prior treatment, and patient health can change the team, hospital support, stay, recovery, and estimate.

Autologous transplant

Delhi bone marrow transplant context: Stem cells are collected from the patient, stored, and returned after high-dose treatment, commonly in selected myeloma, lymphoma, or other protocols.

Collection success and disease response matter.

Matched-related allogeneic BMT

Delhi bone marrow transplant context: Cells come from an HLA-matched relative after donor evaluation; graft-versus-host disease and long-term immune suppression remain relevant.

Related does not guarantee a match.

Haploidentical or unrelated donor

Delhi bone marrow transplant context: Alternative donors expand access but introduce donor-search, procurement, cell transport, protocol, infection, GVHD, and cost considerations.

Confirm the center’s active pathway.

Reduced-intensity or pediatric approach

Delhi bone marrow transplant context: Conditioning and supportive care may be adapted to age, diagnosis, comorbidity, inherited disease, prior treatment, and donor source.

Less intense does not mean low risk.

City treatment pathway

From report review to follow-up in Delhi

1. Hematology record review

Share pathology, marrow reports, flow, genetics, imaging, treatment dates, response, current counts, infection history, organ tests, and preliminary family HLA information.

2. Delhi unit comparison

Confirm diagnosis-specific experience, transplant type, room environment, nursing, apheresis, HLA and blood support, infection response, ICU, expected date, and estimate scope.

3. Restaging and clearance

Delhi bone marrow transplant context: Updated marrow or imaging, organ tests, infection and dental evaluation, psychosocial review, fertility counseling, and donor confirmation establish readiness.

4. Collection or donor procurement

Delhi bone marrow transplant context: The patient or donor receives mobilization and apheresis when required; cells are counted, processed, transported, or stored under unit protocols.

5. Conditioning and infusion

Delhi bone marrow transplant context: Chemotherapy or other conditioning is followed by stem-cell infusion, transfusion support, antimicrobial prophylaxis, symptom control, and daily monitoring.

6. Engraftment and local follow-up

Delhi bone marrow transplant context: Counts, chimerism when relevant, infection, GVHD, organ effects, medicines, nutrition, and revaccination planning guide discharge and later travel.

City cost scenarios

Planning ranges for bone marrow transplant in Delhi

These dated scenarios help compare scope; they are not guaranteed packages. A hospital estimate should replace them after the reports, procedure variant, likely stay, and special requirements are reviewed.

Estimated bone marrow transplant cost scenarios in Delhi
Scenario	INR	USD	Patient context	Planning scope
Autologous BMT	INR 14,00,000 - 20,00,000	USD 14,500 - 20,800	Delhi bone marrow transplant context: Controlled disease, successful collection, standard conditioning, expected engraftment, routine blood support, and no major infection or ICU event.	Delhi bone marrow transplant context: Mobilization and collection allowance, processing, conditioning, infusion, protective admission, routine transfusions, medicines, and defined early review.
Matched allogeneic BMT	INR 20,00,000 - 35,00,000	USD 20,800 - 36,300	Delhi bone marrow transplant context: Suitable matched related donor, planned conditioning, routine GVHD prophylaxis, expected engraftment, and standard inpatient recovery.	Delhi bone marrow transplant context: Recipient and donor work, collection, HLA support, conditioning, infusion, isolation admission, medicines, blood products, and early post-discharge monitoring.
Alternative donor or complicated course	INR 35,00,000 - 52,00,000+	USD 36,300 - 54,000+	Delhi bone marrow transplant context: Haploidentical or unrelated donor, procurement, severe infection, GVHD, graft failure, ICU, prolonged cytopenia, readmission, or intensive salvage treatment.	High-complexity allowance, not a ceiling; donor registry fees, imported cells, long lodging, repeated admissions, and home-country treatment may add further cost.

Usually included

Check what the clinical range covers

Pre-transplant workup

Delhi bone marrow transplant context: Named disease restaging, organ tests, infection screening, specialist consultation, and donor or autologous collection assessment.

Confirm advanced molecular tests.

Cell collection

Delhi bone marrow transplant context: Routine mobilization, apheresis, processing, cryopreservation, and donor collection when specifically included.

Unrelated procurement is often separate.

Conditioning and infusion

Delhi bone marrow transplant context: Standard protocol medicines, central-line care, stem-cell infusion, professional fees, and treatment-room resources.

Drug brands and doses vary.

Protective admission

Delhi bone marrow transplant context: Stated room days, trained nursing, routine laboratory monitoring, transfusions, nutrition support, and standard prophylaxis.

Ask for assumed days.

Early follow-up

Defined post-discharge consultations, blood counts, drug adjustment, and routine monitoring during the first Delhi recovery period.

Chimerism and special tests may differ.

Confirm separately

Costs that may sit outside the range

Unrelated donor procurement

Delhi bone marrow transplant context: Registry search, confirmatory typing, donor medical work, collection, courier, import, and cell transport can sit outside the hospital package.

Request a separate written estimate.

High-cost anti-infectives

Delhi bone marrow transplant context: Special antifungal, antiviral, resistant-bacteria, immunoglobulin, or prolonged antimicrobial treatment may be billed by actual use.

Infection can dominate cost.

GVHD and graft complications

Delhi bone marrow transplant context: Biopsy, endoscopy, extracorporeal therapy, biologics, intensive immunosuppression, graft failure, or second collection may be separate.

Ask about escalation billing.

ICU and readmission

Delhi bone marrow transplant context: Ventilation, vasopressors, dialysis, critical-care procedures, prolonged admission, emergency visits, and repeat hospitalization usually exceed routine scope.

Keep a large contingency.

Living and long follow-up

Delhi bone marrow transplant context: Visa, flights, months of accommodation, food, local transport, caregiver time, medicines, revaccination, and home hematology are non-package costs.

Model the full first year.

Estimate variables

What can change the final hospital cost

Compare the assumptions behind each number, not only the top and bottom of the range.

Transplant type

Delhi bone marrow transplant context: Autologous, matched related, haploidentical, unrelated, or cord pathways use different donor work, medicines, collection, monitoring, and length of stay.

Do not compare one label alone.

Disease status

Delhi bone marrow transplant context: Active disease, residual markers, relapse, heavy prior treatment, or need for bridging therapy changes readiness, complications, and complete cost.

Current restaging is essential.

Conditioning intensity

Delhi bone marrow transplant context: Diagnosis, age, organ reserve, donor, and protocol determine chemotherapy or radiation intensity, medicines, toxicity, and supportive care.

Request regimen assumptions.

Infection and immune recovery

Delhi bone marrow transplant context: Prior resistant infection, prolonged neutropenia, viral reactivation, fungal disease, and slow immune recovery increase diagnostics, drugs, and admission.

Share culture and treatment history.

GVHD or graft failure

Delhi bone marrow transplant context: Allogeneic complications may require biopsies, high-dose medicines, biologics, nutritional support, ICU, readmission, or another graft plan.

No fixed package can cap this.

Delhi stay duration

Delhi bone marrow transplant context: Protective lodging, caregiver support, frequent visits, transport, food, and delayed flights continue after hospital discharge.

Allogeneic recovery is often prolonged.

Hospital capability

Services the hospital should demonstrate

Dedicated transplant unit

Verify positive-pressure or unit-specific environmental controls, trained hematology nurses, central-line practice, visitor rules, cleaning, and rapid response rather than relying on a generic private room.

HLA, apheresis, and cell handling

Delhi bone marrow transplant context: The pathway needs reliable typing, donor search coordination, collection, cell counting, processing, storage, transport, and traceability.

Blood and laboratory support

Irradiated or otherwise appropriate blood products, rapid counts and chemistry, microbiology, pathology, molecular monitoring, and transfusion medicine should be available.

Infection and ICU response

The center needs antimicrobial expertise, imaging, bronchoscopy or other diagnostics, oxygen and intensive care, dialysis, and emergency procedures for deteriorating patients.

Long-term transplant clinic

Confirm chimerism and disease monitoring, GVHD review, medicine supply, revaccination, endocrine and fertility effects, late infection, and remote home-team coordination.

Shortlist questions

Verify capability before the package price

Diagnosis-specific program

Delhi bone marrow transplant context: How often does the unit transplant this disease, age group, remission status, donor type, and conditioning approach?

Ask for relevant rather than universal outcomes.

Room and nursing

Delhi bone marrow transplant context: What environmental controls, staffing, visitor policy, caregiver access, central-line standards, and emergency monitoring apply?

Inspect the actual unit if possible.

Donor search pathway

Delhi bone marrow transplant context: Who manages family typing, unrelated registry search, confirmatory tests, procurement, courier, backup donor, and failed collection?

Clarify external charges.

Estimate assumptions

Delhi bone marrow transplant context: Does cost include collection, conditioning drugs, blood products, room days, anti-infectives, donor expenses, complications, and early follow-up?

Request line items.

Emergency response

Delhi bone marrow transplant context: Can the same campus manage sepsis, respiratory failure, bleeding, kidney injury, neurologic toxicity, and urgent ICU transfer?

Time matters during low counts.

Aftercare ownership

Delhi bone marrow transplant context: Who answers fever calls, reviews new rash or diarrhea, monitors medicines and chimerism, and communicates with the home hematologist?

Get written contact routes.

Treating team

Specialists and support roles that may matter

Transplant hematologist

Confirms indication and timing, selects donor and conditioning, directs collection, infusion, infection prevention, GVHD care, disease monitoring, and long-term follow-up.

Apheresis and transfusion team

Delhi bone marrow transplant context: Collects and handles cells, manages product quality and traceability, and supplies appropriate platelets, red cells, and special blood components.

Infectious disease and critical care

Delhi bone marrow transplant context: Respond to neutropenic fever, resistant infection, viral reactivation, fungal disease, respiratory failure, shock, kidney injury, and treatment toxicity.

Supportive disciplines

Pathology, molecular laboratory, radiology, pharmacy, nutrition, dental care, fertility, psychology, physiotherapy, pediatric care, nursing, and coordination sustain recovery.

City care ecosystem

Support beyond one department

Blood-product access

Frequent transfusion may be needed. Confirm component availability, irradiation requirements, donor policies, replacement expectations, and emergency supply at the selected unit.

Specialized diagnostics

Delhi offers marrow pathology, flow, genetics, imaging, microbiology, and molecular monitoring, but turnaround and on-campus availability should be verified.

High-acuity referral support

Delhi bone marrow transplant context: Pulmonary, kidney, liver, neurologic, gastroenterology, skin, eye, and ICU consultation may be needed for toxicity, infection, or GVHD.

Long-stay housing

Clean, uncrowded accommodation close to the unit with safe food, water, transport, and caregiver relief is part of clinical risk planning, not an optional extra.

Alternative cities

When another Indian center may fit better

No city is the universal choice. Compare referral depth, timing, travel burden, continuity, and complete cost around the individual case.

Gurgaon

Private NCR programs may offer a specific hematologist, room model, donor route, or international service. Compare campus-level infection and ICU capability.

Traffic and long lodging affect total cost.

Mumbai, Chennai, or Bangalore

Another metro may fit a rare disease, pediatric protocol, alternative-donor program, cellular therapy sequence, or existing hematologist relationship.

Compare the same graft and conditioning.

Care closer to home

Some preparation, bridging treatment, transfusion, and later monitoring may safely occur locally if the Delhi transplant team coordinates with a capable home center.

Never fragment care without agreement.

Local logistics

Plan arrival, hospital access, and daily support in Delhi

Travel only when stable

Coordinate blood counts, transfusion, infection status, central line, oxygen needs, and airline clearance before travel; neutropenic or unstable patients need local care.

Live near the BMT unit

Delhi bone marrow transplant context: After discharge, fever or symptoms may require rapid return. Avoid accommodation that depends on long cross-city journeys.

Create a caregiver rota

Delhi bone marrow transplant context: A single caregiver can become exhausted during months of isolation and appointments. Plan backup adults, communication, rest, food, and emergency transport.

Follow unit-specific hygiene

Delhi bone marrow transplant context: Use the center’s rules for visitors, masks, food, water, plants, pets, cleaning, and crowds; generic internet restrictions may be excessive or unsafe.

Protect temperature-sensitive drugs

Delhi bone marrow transplant context: Carry prescriptions, medicine names, refrigeration instructions, spare doses, and letters for injections or controlled products in hand luggage.

Delay tourism and crowds

Early immune recovery is not a normal holiday period. Public transport, crowded sites, construction exposure, and restaurant food should follow transplant-team advice.

Treatment timeline

Expected checkpoints from planning to return home

Remote disease review

The team assesses indication, response, donor options, organ function, infection, and missing tests before suggesting a Delhi evaluation.

Restaging and donor work

Delhi bone marrow transplant context: Marrow or imaging, molecular response, HLA confirmation, donor fitness, fertility, dental, organ, and infection checks establish readiness.

Collection phase

Delhi bone marrow transplant context: Autologous patients or donors receive mobilization and apheresis; unrelated products follow registry, collection, courier, and receipt timelines.

Conditioning and infusion

Delhi bone marrow transplant context: Treatment suppresses disease and marrow, followed by cell infusion and intensive supportive care during profound low counts.

Engraftment and discharge

Delhi bone marrow transplant context: Rising counts, oral intake, controlled infection, manageable symptoms, caregiver readiness, and a safe nearby address support discharge.

Delhi outpatient phase

Delhi bone marrow transplant context: Frequent visits continue for counts, medicines, infection, GVHD, chimerism, disease response, transfusion, and travel readiness.

Recovery and continuity

Protect the handover after discharge

Fever plan

Carry the unit’s temperature threshold, emergency number, nearest emergency route, medication list, central-line details, and instruction not to self-treat first.

GVHD surveillance

Delhi bone marrow transplant context: New rash, diarrhea, jaundice, mouth change, eye dryness, breathing symptoms, or weight loss after allogeneic BMT needs timely specialist review.

Disease monitoring

Delhi bone marrow transplant context: Marrow, imaging, molecular markers, chimerism, or protein studies follow a diagnosis-specific schedule and should continue after travel home.

Nutrition and activity

Food safety, calories, protein, hydration, symptom control, strength, sleep, and gradual activity are individualized around counts, organs, medicines, and GVHD.

Revaccination and late effects

Delhi bone marrow transplant context: Vaccines, fertility, endocrine, bone, heart, lung, kidney, second-cancer, and psychosocial monitoring continue long after blood counts recover.

Home hematology link

The home team needs transplant summary, donor and graft, conditioning, complications, cultures, medicines, transfusion rules, monitoring schedule, and Delhi contacts.

Risks and edge cases

Events that can change eligibility, city, stay, or cost

Severe infection

Delhi bone marrow transplant context: Neutropenia and immune suppression can cause rapidly progressive bacterial, fungal, viral, or opportunistic disease requiring ICU and prolonged drugs.

Fever is time-sensitive.

GVHD

Delhi bone marrow transplant context: Donor immune cells may injure skin, gut, liver, lungs, eyes, or other organs and require prolonged immunosuppression and specialist care.

Applies to allogeneic grafts.

Graft failure or delayed engraftment

Delhi bone marrow transplant context: Persistent low counts can require growth factors, transfusions, infection support, marrow evaluation, donor boost, or another transplant plan.

Cost and stay can rise sharply.

Organ toxicity

Delhi bone marrow transplant context: Conditioning, infection, and medicines may affect heart, lungs, liver, kidneys, nerves, or brain and change eligibility or require intensive treatment.

Pre-transplant testing reduces but cannot remove risk.

Disease relapse

Delhi bone marrow transplant context: The underlying disease can persist or return, leading to medicines, donor lymphocytes, radiation, cellular therapy, another transplant, or supportive care.

Ask how response is monitored.

Collection or donor problem

Delhi bone marrow transplant context: Poor collection, donor illness, scheduling, cell transport delay, or product issue can postpone conditioning or require a backup pathway.

Ask for contingency steps.

Reports for review

Prepare a useful case file before comparing hospitals

Send the original pathology and marrow evidence, not only a diagnosis summary. Disease biology, treatment response, donor information, organ reserve, infections, and transfusion history determine whether and how BMT should proceed.

Upload medical reports

Disease and treatment file

These records define indication, remission status, and prior toxicity.

Pathology and marrow

Delhi bone marrow transplant context: Diagnostic report, marrow aspirate and biopsy, flow cytometry, cytogenetics, FISH, molecular tests, slides or blocks availability, and review history.

Treatment chronology

Delhi bone marrow transplant context: Every regimen, dose and date when available, radiation, surgery, response, relapse, complications, transfusions, admissions, and current treatment.

Current disease status

Delhi bone marrow transplant context: Recent marrow, minimal residual disease, imaging, protein studies, blood counts, symptoms, performance, and treating hematologist assessment.

Organ and infection records

Delhi bone marrow transplant context: Heart, lung, liver, kidney tests, viral markers, tuberculosis, cultures, resistant organisms, fungal history, dental status, medicines, and allergies.

Donor and journey file

Donor and logistics information helps the unit estimate time and risk.

HLA and family map

Delhi bone marrow transplant context: Patient typing, tested relatives, match reports, donor ages and health, previous registry search, antibodies, pregnancies, and transfusions.

Donor health

Delhi bone marrow transplant context: Medical history, medicines, blood counts, infection tests, pregnancy considerations, travel availability, and prior collection or donation.

Caregiver and housing

Named primary and backup caregivers, language, finances, clean lodging, transport, food arrangements, and ability to remain in Delhi.

International planning

Passports, visa status, expected dates, home hematologist, blood-product access, emergency hospital, medicine availability, and return-country laboratory capability.

International patient notes

Documents, payments, language, and attendant planning

Visa timing

Use official Indian visa information and align hospital correspondence with evaluation or transplant dates; donor or caregiver documents may need separate handling.

Donor cells across borders

Unrelated or overseas collection can involve registry, courier, import, timing, viability, backup, and payment processes that must be confirmed before conditioning.

Blood and caregiver planning

Ask about blood-product policy and whether replacement donors are requested. Ensure the caregiver can legally remain through a prolonged and unpredictable Delhi stay.

Home-country readiness

Confirm access to hematology, urgent antibiotics, transfusion, drug levels, chimerism or disease tests, immunosuppressants, and direct Delhi communication.

Procedure-specific planning

Donor selection, infection protection, and GVHD planning

The BMT decision is inseparable from donor source and immune recovery. A lower initial package can become more expensive when donor procurement, prolonged cytopenia, infection, GVHD, or months of protected housing are excluded.

Donor hierarchy

Delhi bone marrow transplant context: Ask why a matched relative, unrelated donor, haploidentical relative, cord source, or autologous cells are preferred for this disease and protocol.

Availability is not the only criterion.

Collection contingency

Delhi bone marrow transplant context: Clarify target cell dose, collection days, poor mobilization response, donor illness, backup donor, processing, storage, and transport delays.

Conditioning should follow product readiness.

Infection history

Delhi bone marrow transplant context: Prior resistant bacteria, fungal disease, tuberculosis, hepatitis, CMV, other viruses, and central-line infection shape prophylaxis and monitoring.

Send microbiology reports.

GVHD prevention

Delhi bone marrow transplant context: Conditioning, graft source, donor match, cell manipulation, and medicines determine prevention and surveillance; ask what symptoms trigger urgent review.

Long-term treatment may be needed.

Fertility preservation

Delhi bone marrow transplant context: Discuss sperm, egg, embryo, ovarian, or other preservation before conditioning when medically and legally appropriate and time allows.

Treatment urgency can limit options.

Late-effect care

Delhi bone marrow transplant context: Plan revaccination and monitoring for endocrine, fertility, bone, heart, lung, kidney, eye, oral, psychological, and second-cancer effects.

Recovery continues for years.

Consultation checklist

Questions to ask the hospital and treating team

Why BMT, and why now?

Delhi bone marrow transplant context: Ask how disease risk, response, alternatives, relapse probability, and transplant-related risk support the recommendation.

Why this donor and conditioning?

Delhi bone marrow transplant context: Request a plain explanation of match, source, collection, intensity, GVHD prevention, and backup plan.

How does the unit prevent infection?

Delhi bone marrow transplant context: Clarify room controls, nursing, food, visitor, line, antimicrobial, microbiology, imaging, and ICU practices.

Which costs are variable?

Delhi bone marrow transplant context: Ask about donor search, cells, blood, high-cost drugs, extra room days, GVHD, infection, ICU, readmission, and outpatient medicines.

What keeps us in Delhi?

Delhi bone marrow transplant context: Discuss counts, transfusion independence, infection, GVHD, medicines, caregiver readiness, housing, and travel clearance.

Who manages late complications?

Name Delhi and home clinicians for fever, GVHD, relapse monitoring, vaccination, fertility, organ effects, and emergency return.

Common questions

Questions about treatment in Delhi

How much does bone marrow transplant cost in Delhi?

Autologous BMT may be planned at INR 14,00,000 to 20,00,000. Matched allogeneic care may be INR 20,00,000 to 35,00,000, while haploidentical, unrelated-donor, infection, GVHD, ICU, or graft-failure pathways may reach INR 35,00,000 to 52,00,000 or more. Ask whether donor procurement and high-cost medicines are included.

Is bone marrow transplant surgery?

Stem cells are usually infused through a vein after conditioning; it is not an operation like organ transplantation. However, the pathway is medically intensive because conditioning suppresses marrow and immunity, requiring central-line care, blood products, infection protection, daily monitoring, and management of transplant complications.

How is a donor matched?

HLA typing and disease-specific considerations guide donor selection. A matched sibling may not exist, so a team may evaluate another relative, unrelated registry donor, haploidentical donor, or cord source. The preferred route depends on diagnosis, urgency, age, antibodies, protocol, availability, and center experience.

How long must an international patient stay in Delhi?

Autologous patients may need several weeks after discharge; allogeneic families should often plan eight to sixteen weeks or longer. Count recovery, transfusion, infection, GVHD, medicine adjustment, donor or cell timing, and local housing can extend the stay unpredictably.

Can the patient stay in a hotel after BMT?

Only if the transplant team approves the property and timing. Accommodation should be clean, uncrowded, close to the unit, and suitable for safe food, water, medicine storage, and emergency transport. Unit-specific infection rules matter more than the word hotel or apartment.

What is graft-versus-host disease?

After allogeneic BMT, donor immune cells can attack recipient tissues, commonly affecting skin, gut, liver, lungs, eyes, or mouth. Prevention and treatment depend on donor, graft, conditioning, and symptoms. New rash, diarrhea, jaundice, breathing change, or severe dryness needs prompt review.

Are blood products included in a BMT package?

A routine allowance may be included, but the number and type of red-cell and platelet transfusions vary with counts, bleeding, infection, graft function, and complications. Ask about component type, irradiation, replacement-donor policy, unit charges, and what happens after the included allowance.

Can BMT be planned if infection is present?

The team weighs infection type, site, organism, response, disease urgency, donor timing, and conditioning risk. Some infections must be controlled before transplant; others require a specialized plan. Never conceal prior cultures, resistant organisms, tuberculosis, fungal disease, or antimicrobial exposure.

Does Delhi offer pediatric BMT?

Selected Delhi units manage children, but families should verify pediatric hematology, age-appropriate transplant experience, dosing, intensive care, infection support, nutrition, psychology, schooling, caregiver accommodation, and the exact inherited or malignant diagnosis rather than assuming an adult unit is equivalent.

Which reports should be reviewed first?

Send diagnostic pathology and marrow, flow cytometry, genetics, molecular markers, all treatments and response tests, current blood counts, organ assessments, infection and culture history, transfusions, HLA reports, donor information, medicines, and the home hematologist’s current recommendation.

Review and sources

How this city guide was prepared

This guide combines official Delhi institutional evidence, recognized transplant education, infection and GVHD planning principles, and Virello Health cost benchmarks. The scenarios separate autologous, matched allogeneic, and alternative-donor or complicated pathways and use the RBI reference displayed for 17 July 2026. They are not quotes or success predictions. Unit capability, donor source, medicines, room conditions, and every clinical statement require case-level confirmation.

This information does not diagnose a blood disorder, decide BMT candidacy, select a donor, replace urgent infection treatment, or guarantee engraftment, outcome, cost, or timing. The treating hematology transplant team must review complete disease, donor, organ, infection, and psychosocial information.

Transplant immunology and immunogenetics (opens in a new tab)

AIIMS New Delhi · Accessed 2026-07-20

Supports: Delhi HLA testing and marrow-transplant immunology context.

Stem cell transplantation patient information (opens in a new tab)

National Cancer Institute · Accessed 2026-07-20

Supports: Autologous and allogeneic treatment, conditioning, and recovery concepts.

Hematopoietic cell transplant guidelines (opens in a new tab)

European Society for Blood and Marrow Transplantation · Accessed 2026-07-20

Supports: Donor, conditioning, infection, GVHD, and follow-up framework.

Donor and transplant education (opens in a new tab)

NMDP · Accessed 2026-07-20

Supports: Donor matching, collection, patient preparation, and recovery education.

Cancer surgical and critical-care services (opens in a new tab)

AIIMS New Delhi · Accessed 2026-07-20

Supports: Delhi oncology, ICU, operation, and multidisciplinary referral context.

Indian medical visa service (opens in a new tab)

Government of India · Accessed 2026-07-20

Supports: Official international patient and attendant visa route.

Airport health organization Delhi (opens in a new tab)

Ministry of Health and Family Welfare · Accessed 2026-07-20

Supports: Medical inspection facility context at IGI Terminal 3.

RBI reference-rate release (opens in a new tab)

Reserve Bank of India · Accessed 2026-07-20

Supports: INR 96.3665 per USD planning conversion dated 17 July 2026.

Related planning